Medical devices with local physical action: understanding the principle

Distinguish the mechanism from the intended benefit

A mode of action is not clinical evidence. Explaining how a formulation works is not enough to demonstrate what a patient can expect from it. The mechanism describes how it functions; clinical data describe results observed in a defined population and under specified conditions.

This distinction helps partners read a product page and prepare an accurate commercial presentation. It avoids turning a general explanation of the technology into an identical promise for every product.

The film's role on the treated surface

VITROBIO technology combines glycerol and polymers in a film-forming formulation. The film is deposited at the application surface. It forms an interface between the mucosa and its environment, with functions that depend on the product and its indication.

Glycerol contributes to fluid exchanges through osmosis. Its association with certain polymers helps stabilise the film against dilution. Other polymers are selected for their affinity with agents or mediators targeted by the formulation, retaining them within the film.

The PolymR technology presentation explains this approach. The scientific FAQ provides further information on film-forming glycerol and polymer selection.

Why formulations differ by indication

Nasal mucosa and an oral surface do not involve the same use. Application site, conditions of use and product objectives guide the formulation. Film persistence should therefore not be generalised from a single example.

Likewise, local action does not remove the need to review tolerability, precautions and limitations of use. Instructions remain specific to each device. For nasal needs, our article on colds and allergic rhinitis explains why similar symptoms can have different causes.

Read clinical results without extrapolating

Before including a result in a presentation, ask four questions:

• Which formulation was studied, and does it match the product presented?
• Which patients took part and for which indication?
• Which endpoint was measured, when and against which comparator?
• Which limitations do the authors identify?

A result on a symptom score is not automatically a result on disease duration. An observation in adults cannot, on its own, describe an effect in children. The presentation must retain the context needed to understand the result.

Apply this understanding to a product range

For a partner, this approach connects three elements: the market need, the available product and the supporting data. The VITROBIO medical device catalogue allows you to explore indications; each product page then provides product-specific information.

The guide to documents to review under MDR complements this reading. To explore marketing under your brand, tell our laboratory about your project.

VITROBIO sources

The technology explanations in this article draw on the PolymR page and the laboratory's scientific answers. Indications and performance should be checked in each product's own documentation.